Regulatory Criteria
Regulatory Criteria - Related Videos
01:28
Criteria for Causality: Bradford Hill Criteria - II
0 Views •
2025
The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts: Biological Gradient: Also known as the dose-response relationship, this criterion...
01:30
Criteria for Causality: Bradford Hill Criteria - I
0 Views •
2025
The Bradford Hill criteria are a group of principles that provide a framework to determine a causal relationship between a specific factor and a disease. There are nine criteria that are pivotal in assessing causality in epidemiological studies. Here's a closer look at Strength, Consistency, Specificity, and Temporality criteria with definitions and examples: Strength: This criterion refers to the size of the association between the factor and the outcome. A strong association suggests a...
02:02
Cis-regulatory Sequences
0 Views •
2020
Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
09:27
New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
0 Views •
Cited by 4 •
2013
CD4+ Regulatory T cells are potent immune-modulators and serve important functions in immune homeostasis. The paucity of these cells in peripheral blood makes functional studies challenging, specifically in the context of HIV-1-infection. We here describe a method to isolate and expand functional CD4+ Tregs from peripheral blood from HIV-1-infected individuals.
16:26
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
0 Views •
Cited by 2 •
2007
FAQs
These criteria work as a multidimensional review rather than a single pass-or-fail measure. Safety protects participants, quality supports dependable conduct and production, efficacy addresses whether an intervention works, and ethical requirements govern participant treatment. Considering these dimensions together helps regulators judge evidence without separating scientific performance from participant protection.
Predefined requirements make regulatory decisions more consistent across studies and submissions. Researchers can use them to plan evidence collection, explain why key decisions were made, and organize records for review. The same structure also helps reviewers compare findings across submissions, reducing ambiguity about which evidence supports a conclusion.
Review focuses not only on reported findings but also on how the evidence was generated. Study design, participant eligibility, informed consent, data integrity, and clinically meaningful outcomes each address a different source of uncertainty. Together, they help determine whether results are trustworthy, ethically obtained, and relevant to decisions about clinical use.
When applying regulatory criteria to a clinical study, teams should address the design, eligibility rules, consent process, data handling, and outcome measures from the outset. They then document decisions and supporting evidence in a form that can be examined. This approach links operational choices to participant protection and interpretability.
Medical product evaluation extends beyond clinical findings to include manufacturing controls. These controls provide part of the evidence that a product is produced with appropriate quality while its safety and efficacy are assessed. Including production information in the review creates a fuller basis for authorization and for confidence in later use.
Meeting regulatory criteria can support several stages of a product or practice’s life cycle, including authorization, monitoring, and continued use. The criteria also help connect research findings with evidence-based clinical practice. Their value therefore extends beyond an initial decision: they provide a framework for maintaining confidence as evidence is reviewed and applied.